Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for ...

Andrew Kuykendall, MD, is an investigator on the phase 3 VERIFY trial (NCT05210790), findings from which demonstrate the safety, reliability, and effectiveness of rusfertide to treat polycythemia vera ...